Published in

Taylor and Francis Group, Leukemia & Lymphoma, 3(52), p. 409-416

DOI: 10.3109/10428194.2010.543717

Links

Tools

Export citation

Search in Google Scholar

Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03)

Journal article published in 2011 by José Francisco Tomás, Carlos Montalbán, Alberto Fernández De Sevilla, JoaquÍn MartÍnez-López, Nicolás DÍaz, Miguel Canales, Rafael MartÍnez, Pedro Sánchez-Godoy, MarÍa Dolores Caballero, Javier Peñalver, Elena Prieto, Antonio Salar ORCID, Carmen Burgaleta, José Antonio Queizán, Roberto Bajo and other authors.
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO